Cargando…
STIM1 in tumor cell death: angel or devil?
Stromal interaction molecule 1 (STIM1) is involved in mediating the store-operated Ca(2+) entry (SOCE), driving the influx of the intracellular second messenger calcium ion (Ca(2+)), which is closely associated with tumor cell proliferation, metastasis, apoptosis, autophagy, metabolism and immune pr...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628139/ https://www.ncbi.nlm.nih.gov/pubmed/37932320 http://dx.doi.org/10.1038/s41420-023-01703-8 |
_version_ | 1785131690329374720 |
---|---|
author | Ren, Ran Li, Yongsheng |
author_facet | Ren, Ran Li, Yongsheng |
author_sort | Ren, Ran |
collection | PubMed |
description | Stromal interaction molecule 1 (STIM1) is involved in mediating the store-operated Ca(2+) entry (SOCE), driving the influx of the intracellular second messenger calcium ion (Ca(2+)), which is closely associated with tumor cell proliferation, metastasis, apoptosis, autophagy, metabolism and immune processes. STIM1 is not only regulated at the transcriptional level by NF-κB and HIF-1, but also post-transcriptionally modified by miRNAs and degraded by ubiquitination. Recent studies have shown that STIM1 or Ca(2+) signaling can regulate apoptosis, autophagy, pyroptosis, and ferroptosis in tumor cells and act discrepantly in different cancers. Furthermore, STIM1 contributes to resistance against antitumor therapy by influencing tumor cell death. Further investigation into the mechanisms through which STIM1 controls other forms of tumor cell death could aid in the discovery of novel therapeutic targets. Moreover, STIM1 has the ability to regulate immune cells within the tumor microenvironment. Here, we review the basic structure, function and regulation of STIM1, summarize the signaling pathways through which STIM1 regulates tumor cell death, and propose the prospects of antitumor therapy by targeting STIM1. |
format | Online Article Text |
id | pubmed-10628139 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-106281392023-11-08 STIM1 in tumor cell death: angel or devil? Ren, Ran Li, Yongsheng Cell Death Discov Review Article Stromal interaction molecule 1 (STIM1) is involved in mediating the store-operated Ca(2+) entry (SOCE), driving the influx of the intracellular second messenger calcium ion (Ca(2+)), which is closely associated with tumor cell proliferation, metastasis, apoptosis, autophagy, metabolism and immune processes. STIM1 is not only regulated at the transcriptional level by NF-κB and HIF-1, but also post-transcriptionally modified by miRNAs and degraded by ubiquitination. Recent studies have shown that STIM1 or Ca(2+) signaling can regulate apoptosis, autophagy, pyroptosis, and ferroptosis in tumor cells and act discrepantly in different cancers. Furthermore, STIM1 contributes to resistance against antitumor therapy by influencing tumor cell death. Further investigation into the mechanisms through which STIM1 controls other forms of tumor cell death could aid in the discovery of novel therapeutic targets. Moreover, STIM1 has the ability to regulate immune cells within the tumor microenvironment. Here, we review the basic structure, function and regulation of STIM1, summarize the signaling pathways through which STIM1 regulates tumor cell death, and propose the prospects of antitumor therapy by targeting STIM1. Nature Publishing Group UK 2023-11-06 /pmc/articles/PMC10628139/ /pubmed/37932320 http://dx.doi.org/10.1038/s41420-023-01703-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Review Article Ren, Ran Li, Yongsheng STIM1 in tumor cell death: angel or devil? |
title | STIM1 in tumor cell death: angel or devil? |
title_full | STIM1 in tumor cell death: angel or devil? |
title_fullStr | STIM1 in tumor cell death: angel or devil? |
title_full_unstemmed | STIM1 in tumor cell death: angel or devil? |
title_short | STIM1 in tumor cell death: angel or devil? |
title_sort | stim1 in tumor cell death: angel or devil? |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628139/ https://www.ncbi.nlm.nih.gov/pubmed/37932320 http://dx.doi.org/10.1038/s41420-023-01703-8 |
work_keys_str_mv | AT renran stim1intumorcelldeathangelordevil AT liyongsheng stim1intumorcelldeathangelordevil |